US 9598424
Heteroarylamide inhibitors of TBK1
granted A61PA61P29/00A61P37/00
Quick answer
US patent 9598424 (Heteroarylamide inhibitors of TBK1) held by Takeda Pharmaceutical Company Limited expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P29/00, A61P37/00